对CXC化学受体3的激活和抑制的结构性见解
Haizhan Jiao1, Bin Pang2, Aijun Liu1
1Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Shenzhen, China.
研究人员阐明了CXCR3受体激活和抑制的结构基础. 了解这些机制,包括化学因子和新型激动剂/对抗剂,为开发新型1型免疫药物提供了洞察力.
科学领域:
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化学因子受体CXCR3 (CXC化学因子受体3) 和它的配体 (CXCL9-11) 对于1型免疫非常重要,指导T细胞迁移.
- 对CXCR3信号的失调与各种免疫相关疾病有关.
研究的目的:
- 确定人体CXCR3的结构,与各种激动剂和对抗剂复合.
- 阐明CXCR3激活和抑制背后的分子机制.
主要方法:
- 使用X射线结晶学来确定CXCR3复合物的结构.
- 生物化学分析被用来描述调节剂的药理性质.
主要成果:
- 结构显示了激动剂CXCL11,PS372424和VUF11222的独特结合模式.
- 在5号和6号跨膜螺旋之间确定了对抗剂SCH546738的新型全结位.
- SCH546738似乎可以稳定一个不活跃的受体结构.
结论:
- 该研究提供了详细的结构洞察力,了解不同类型的配体对CXCR3的激活.
- 这些发现揭示了CXCR3的全抑制机制.
- 这项工作为基于结构的药物设计奠定了基础,该设计针对CXCR3进行免疫调节.
更多相关视频
10:03Rapid and Robust Analysis of Cellular and Molecular Polarization Induced by Chemokine Signaling
Published on: December 12, 2014
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Co-activators and Co-repressors
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The JAK-STAT Signaling Pathway
Ligand-Gated Ion Channel Receptor: Gating Mechanism
